e-learning
resources
London 2016
Sunday, 04.09.2016
Features and impact of comorbidities in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Impact of comorbidities in COPD prognosys scores
Amaia Aramburu Ojembarrena (Galdakao, Spain), Amaia Aramburu Ojembarrena, Inmaculada Arostegui, Txomin Zabala, Amaia Garcia, Irantzu Barrio, Francisco Javier Moraza, Ane Uranga, Alberto Capelastegui, Cristobal Esteban
Source:
International Congress 2016 – Features and impact of comorbidities in COPD
Session:
Features and impact of comorbidities in COPD
Session type:
Thematic Poster
Number:
646
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Amaia Aramburu Ojembarrena (Galdakao, Spain), Amaia Aramburu Ojembarrena, Inmaculada Arostegui, Txomin Zabala, Amaia Garcia, Irantzu Barrio, Francisco Javier Moraza, Ane Uranga, Alberto Capelastegui, Cristobal Esteban. Impact of comorbidities in COPD prognosys scores. Eur Respir J 2016; 48: Suppl. 60, 646
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Renal impairment a neglected comorbidity in patients with COPD
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
The severity of anxiety in COPD patients (pts)
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
The relation of comorbidities with the exacerbation severity in patients with COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
COPD and depression: Prevalence and interaction
Source: International Congress 2014 – Comorbidities
Year: 2014
Comorbidities in patients with COPD and their impact on COPD course
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
The distribution of phenotypes in a population of severe COPD
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014
Prevalence of co-morbidities in severe asthma, COPD and overlap syndrome
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Mortality and readmissions in patients with severe COPD. Validation of the CODEX index
Source: International Congress 2015 – Best abstracts in COPD management
Year: 2015
The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014
COPD: Influence of patients’ nutritive status on the exacerbations rate
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Evaluation of arrhythmia frequency in patients with COPD
Source: International Congress 2015 – Different data in COPD
Year: 2015
The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Impact of bronchiectasis on the course of COPD
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Comparing the prevalence of depression and anxiety in patients admitted with an exacerbation of COPD using two scoring systems
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015
Alexithymia in COPD patients
Source: International Congress 2015 – Clinical problems in acute and chronic lung diseases
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept